| Thu, 19 Jul 2018 14:45:10: | Novartis nabs much-needed new nod for slow-growing breast cancer drug Kisqali
|
| Thu, 19 Jul 2018 13:46:35: | Is Roche's latest Tecentriq win really a win for Merck's Keytruda?
|
| Wed, 18 Jul 2018 15:38:06: | FDA nails Baxter with warning letter for plant picked up in Claris buyout
|
| Wed, 18 Jul 2018 15:27:54: | Roche's Tecentriq extends its hot streak with liver cancer combo breakthrough
|
| Wed, 18 Jul 2018 14:01:33: | Under scrutiny for Cohen deal, Novartis calls off further price hikes in 2018
|
| Wed, 18 Jul 2018 13:46:14: | Eisai obesity drug Belviq may have an edge with new heart-safety data—but to what end?
|
| Wed, 18 Jul 2018 13:05:44: | Evoke Group’s expansion drive continues with West Coast agency buy
|
| Tue, 17 Jul 2018 15:22:12: | Vertex says it's glad England made another offer for CF drugs, but it'll have to do better
|
| Tue, 17 Jul 2018 14:27:51: | Johnson & Johnson predicts 4% to 6% net price decline in pharma this year, with Remicade down by double digits in Q2
|
| Tue, 17 Jul 2018 14:25:34: | Winning Trump’s praise was easy for Pfizer. Wall Street and the Hill? Not so much
|
| Tue, 17 Jul 2018 14:21:06: | Johnson & Johnson softens FDA's Invokana blow with positive kidney results
|
| Tue, 17 Jul 2018 12:23:50: | Moderna opens $110M manufacturing site for its mRNA program
|
| Mon, 16 Jul 2018 19:52:15: | Pfizer halts production at India injectables plant after FDA again finds issues
|
| Mon, 16 Jul 2018 14:45:14: | Could Amgen soften the Neulasta biosimilar blow with an Alexion buy?
|
| Mon, 16 Jul 2018 14:25:21: | Purdue defends against opioid lawsuits by pointing to FDA regulations it helped create
|
| Mon, 16 Jul 2018 14:07:26: | Will Mylan’s big Copaxone price break force Teva’s hand? Clients are pushing already
|
| Mon, 16 Jul 2018 13:36:31: | With FDA nod, Pfizer and Astellas’ Xtandi gets its shot at blockbuster sales boost
|
| Mon, 16 Jul 2018 13:14:12: | Ogilvy CommonHealth’s North America CEO snags new chief creative officer
|
| Mon, 16 Jul 2018 13:14:11: | FDA looks at incentives, manufacturing ‘interventions’ to solve drug shortages
|
| Mon, 16 Jul 2018 13:05:25: | FDA joins EU in seeking recall of certain Chinese-made valsartan products over potential cancer risk
|
| Sun, 15 Jul 2018 16:55:19: | Bayer works to connect brand to products with all-American TV ad
|
| Sun, 15 Jul 2018 14:24:06: | Hemophilia, the musical: BioMarin sponsors one-of-a-kind performance created by teens
|
| Fri, 13 Jul 2018 16:59:36: | McCann Health fires chief creative officer over conduct code violation
|
| Fri, 13 Jul 2018 14:31:24: | Senators challenge Novartis' account of Cohen deal, calling it 'longer and more detailed' than disclosed
|
| Fri, 13 Jul 2018 14:16:59: | Adempas maker Bayer connects hypertension patients with new mentoring group
|
